Author:
Petrelli Fausto,Perego Gianluca,Ghidini Antonio,Ghidini Michele,Borgonovo Karen,Scolari Cinzia,Nozza Renata,Rampulla Valentina,Costanzo Antonio,Varricchio Antonio,Rausa Emanuele,Pietrantonio Filippo,Zaniboni Alberto
Publisher
Springer Science and Business Media LLC
Reference85 articles.
1. International Agency for Research on Cancer (IARC) (2018) GLOBOCAN 2018: Latest global cancer data. CA Cancer J Clin 68(September):13–15
2. Gruppo di Lavoro AIRTum- Aiom. I Numeri Del Cancro in Italia. 2017. http://www.registri-tumori.it/PDF/AIOM2014/I_numeri_del_cancro_2014.pdf. Accessed Aug 2019
3. Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJ (2007 Nov 15) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357(20):2040–2048
4. Van Cutsem E, Peeters M, Siena S et al (2007) Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 25(13):1658–1664. https://doi.org/10.1200/JCO.2006.08.1620
5. Foubert F, Matysiak-Budnik T, Touchefeu Y (2014) Options for metastatic colorectal cancer beyond the second line of treatment. Dig Liver Dis 46(2):105–112. https://doi.org/10.1016/j.dld.2013.07.002
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献